You're reading the free version. Trader adds the live tape and alerts.
Start tracking
SCTX Conversion Disclosure
Gordon Carl L · SEC Form 4 · Filed Jul 29, 2026
Conversion
Reported value range
Not reported
Gordon Carl L Director
SCTX
Transaction date
Jul 27, 2026
Public filing date
Jul 29, 2026
Filing lag
Filed 2 days later
SCTX daily price context
No linked price history
This asset is not matched to a market-data symbol.
Source details
- Reported owner
- Not disclosed
- Source asset code
- Security
- Security
- Common Stock
- Quantity / price
- 348,825 shares
- SEC ownership
- Indirect
- Transaction code
- C
- Form
- 4
- Filing identifier
- 0000947871-26-000734
Filing cohort
Transactions in this filing
Showing 3 of 3
Trades
3
Issuers
1
Estimated value
$15M
Buys / sales
1 / 0
| Issuer | Transaction | Traded | Value |
|---|---|---|---|
| Scribe Therapeutics, Inc. SCTX Current | Conversion | Jul 27, 2026 | Not reported |
| Scribe Therapeutics, Inc. SCTX | Buy | Jul 27, 2026 | $15M |
| Scribe Therapeutics, Inc. SCTX | Conversion | Jul 27, 2026 | $0 |